Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-13-004131
Filing Date
2013-08-12
Accepted
2013-08-12 09:20:04
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0613_soligenix.htm 10-Q 713874
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER f10q0613ex31i_soligenix.htm EX-31.1 13782
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER f10q0613ex31ii_soligenix.htm EX-31.2 13759
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER f10q0613ex32i_soligenix.htm EX-32.1 5631
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER f10q0613ex32ii_soligenix.htm EX-32.2 5919
  Complete submission text file 0001213900-13-004131.txt   6044512

Data Files

Seq Description Document Type Size
6 sngx-20130630.xml EX-101.INS 693681
7 sngx-20130630.xsd EX-101.SCH 29875
8 sngx-20130630_cal.xml EX-101.CAL 28323
9 sngx-20130630_def.xml EX-101.DEF 77689
10 sngx-20130630_lab.xml EX-101.LAB 276217
11 sngx-20130630_pre.xml EX-101.PRE 180016
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

EIN.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-16929 | Film No.: 131028405
SIC: 2834 Pharmaceutical Preparations